“…New approaches for the synthesis of naturally occurring bioactive pyran derivatives have appeared. Different routes have been established for the total synthesis of tetrahydropyran-containing natural compounds brevisamide (16EJO2300, 16JOC3799), (±)-centrolobine (16SL2221), (−)-clavosolide A (16AGE2498), (+)-decarestrictine L (16TL4368), decytospolide A, B, and their C-3 epimers (16S765), goniodomin A (16JOC2213), herboxidiene (16OBC6212), irciniastatins (16JOC1930), (−)-lasonolide A (16JA11690), (−)-luminacin D (16JOC3818), (−)-mandelalide A (16JA770, 16JA3675), isomandelalide A (16JA770), thailanstatin A (16JA7532); of the 2H-pyran-2-ones sibirinone, (E)-6-(pent-1-en-1-yl)-2H-pyran-2-one and (E)-6-(hept-1-en-1-yl)-2H-pyran-2-one (16JOC10357); of the 5,6-dihydropyran-2-one derivatives cryptomoscatone F1 (16S1561), cryptorigidifoliol B (16TL2100), cryptorigidifoliol E (16S4213), 8-methoxygoniodiol (16S4300), pectinolides A, C, and H (16HCA247); and of the tetrahydropyran-2-one derivatives (−)-(S)-goniothalamin and (−)-leiocarpin (16SC187), helicascolides A, B, and C (16AGE5765), isodaphlongamine H (16AGE2577), and (−)-malyngolide and its C-5 epimer (16HCA267).…”